発射分子が保たれたブレイディアリズムに最適な発射戦略は? ネットワークのメタ解析
Patavee Pajareya1, Watsapon Chuanchai1, Noppachai Siranart1
1Faculty of Medicine, King Chulalongkorn Memorial Hospital, Chulalongkorn University, Bangkok, TH.
Heart rhythm
|August 21, 2025
まとめ
左ブンドルブランチエリアペース (LBBAP) は,発射分子が保存されたブラディアルリズムに効果があり,死亡率と心不全の入院を減少させます. 心臓の生理的なペースを 調整する第一線戦略です
科学分野:
- 心臓病科
- 電気生理学
- 心臓のペース
背景:
- 心筋病変のリスクが低いため,右心室ペース (RVP) よりも心臓生理ペース (CPP) が好ましい.
- 保存された左心室射出分数 (LVEF) のブラディアルリズムにおけるCPPの証拠は限られている.
研究 の 目的:
- ブラディアルリズムにおけるRVPに対する異なるCPP戦略の結果と保存されたLVEFを比較する.
- バイブントリキュラー・ペーシング (BiVP),LBBAP,ヒス・バンドル・ペーシング (HBP) の有効性と安全性を評価する.
主な方法:
- 8795人の患者を対象とした29件のネットワークメタ解析.
- 含有基準: ブラディアリズム症の成人,平均LVEF ≥50%または<10%,対照比較.
- 主要エンドポイントは,全因死亡率と心不全入院 (HHF) の複合です.
主要な成果:
- RVPと比較して,LBBAPは複合プライマリエンドポイントを有意に低下させた (OR0. 42,p=0. 001).
- LBBAPは最も低い不協和度指数と最も狭いペースのQRS期間を示した.
- BiVPは最も高いLVEFを示し,HBPは最も低い処置成功と最も高い合併症を示した.
結論:
- LBBAPは,保存されたLVEFのブラディアルリズムに対する第一線CPP戦略として潜在性を示しています.
- LBBAPがHHFと全因死亡率を減らすという効果は,その使用を支持している.
- この患者集団におけるLBBAPの役割は,さらなる研究によって確証される可能性がある.
関連する概念動画
Dysrhythmias IV: Characteristics of Bradyarrhythmias
118
Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
118
Decreased pulse rate
619
Bradycardia is a medical condition in which the heart rate is slower than normal. It occurs when the heart's natural pacemaker, the sinus node, generates slower electrical impulses than the standard rhythm. In adults, bradycardia is diagnosed when the pulse rate falls below 60 beats per minute, indicating a deviation from the normal heart rate range.
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
619
Dysrhythmias VI: Management of Dysrhythmias
106
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
106
Disturbances in Heart Rhythm
1.2K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
1.2K
Dysrhythmias III: Characteristics of Dysrhythmias
114
Dysrhythmias, also known as arrhythmias, are irregular heart rhythms that result from abnormal electrical activity in the heart, affecting its ability to circulate blood efficiently. Tachyarrhythmias, a subset of dysrhythmias, are characterized by abnormally fast heart rates exceeding 100 beats per minute. Here are some types of tachyarrhythmias with their distinct ECG features:Sinus Tachycardia:Sinus tachycardia presents a regular heart rhythm with an increased rate of 101-180 beats per...
114
Heart Failure Drugs: β-Blockers
434
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
434


